Outcomes of patients with IDH1-mutant relapsed or refractory acute myeloid leukemia receiving ivosidenib who proceeded to hematopoietic stem cell transplant.

ABSTRACT:

SUBMITTER: DiNardo CD 

PROVIDER: S-EPMC8464620 | biostudies-literature | 2021 Nov

REPOSITORIES: biostudies-literature